Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Main Authors: | , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
BMC
2023-05-01
|
| 叢編: | Journal of Translational Medicine |
| 在線閱讀: | https://doi.org/10.1186/s12967-023-04186-4 |